当前位置:
X-MOL 学术
›
Int. J. Stem Cells
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
miR-29a in Exosomes from Bone Marrow Mesenchymal Stem Cells Inhibit Fibrosis during Endometrial Repair of Intrauterine Adhesion.
International Journal of Stem Cells ( IF 2.5 ) Pub Date : 2020-12-1 , DOI: 10.15283/ijsc20049 Qingqing Tan 1 , Dandan Xia 1 , Xiaoyan Ying 2
International Journal of Stem Cells ( IF 2.5 ) Pub Date : 2020-12-1 , DOI: 10.15283/ijsc20049 Qingqing Tan 1 , Dandan Xia 1 , Xiaoyan Ying 2
Affiliation
Bone marrow mesenchymal stem cells (BMSCs) is an ideal source of stem cells in the treatment of intrauterine adhesion. Exosomes are a type of membrane vesicle and the diameter is 30∼100 nm. Exosomes can take their contents into the target cells, releasing and exerting their functions. In this study, we intend to study the role of human BMSC-derived exosomes (BMSC-Exo) in promoting endometrial damage repair in the treatment of IUA.
中文翻译:
骨髓间充质干细胞外泌体中的 miR-29a 在子宫内膜修复子宫内粘连期间抑制纤维化。
骨髓间充质干细胞(BMSCs)是治疗宫腔粘连的理想干细胞来源。外泌体是一种膜囊泡,直径为 30~100 nm。外泌体可以将其内容物带入靶细胞,释放并发挥其功能。在这项研究中,我们打算研究人骨髓间充质干细胞来源的外泌体(BMSC-Exo)在促进子宫内膜损伤修复中治疗IUA中的作用。
更新日期:2020-12-02
中文翻译:
骨髓间充质干细胞外泌体中的 miR-29a 在子宫内膜修复子宫内粘连期间抑制纤维化。
骨髓间充质干细胞(BMSCs)是治疗宫腔粘连的理想干细胞来源。外泌体是一种膜囊泡,直径为 30~100 nm。外泌体可以将其内容物带入靶细胞,释放并发挥其功能。在这项研究中,我们打算研究人骨髓间充质干细胞来源的外泌体(BMSC-Exo)在促进子宫内膜损伤修复中治疗IUA中的作用。